
KoBioLabs, Inc. — Investor Relations & Filings
KoBioLabs, Inc. is a biotechnology company that develops innovative microbiome-based therapeutics. The company utilizes its proprietary Smartiome® platform, an integrated system for discovering novel drug candidates that employs AI-driven multi-omics analysis and a comprehensive microbiome library with a reverse-translation approach. KoBioLabs is focused on creating a pipeline of new drugs to treat a range of immune, metabolic, and brain disorders. The company also applies advanced technologies, including a microbe-based drug delivery system (mDDS) and biofoundry techniques, to enhance the efficacy of its treatments and address unmet medical needs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 증권발행결과(자율공시)(제2회차) | 2021-12-30 | Korean | |
| 증권발행결과(자율공시)(제3자배정-전환우선주) | 2021-12-29 | Korean | |
| 주요사항보고서(유상증자결정) | 2021-12-21 | Korean | |
| 주요사항보고서(전환사채권발행결정) | 2021-12-21 | Korean | |
| 주주명부폐쇄기간또는기준일설정 | 2021-12-14 | Korean | |
| 기타경영사항(특허권취득)(자율공시)(락토바실러스 플란타럼 KBL396 균주 및 그 용도-일본) | 2021-12-10 | Korean |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2021
15 filings
| |||||
| 8841933 | 증권발행결과(자율공시)(제2회차) | 2021-12-30 | Korean | ||
| 8842924 | 증권발행결과(자율공시)(제3자배정-전환우선주) | 2021-12-29 | Korean | ||
| 8848262 | 주요사항보고서(유상증자결정) | 2021-12-21 | Korean | ||
| 8848108 | 주요사항보고서(전환사채권발행결정) | 2021-12-21 | Korean | ||
| 8855126 | 주주명부폐쇄기간또는기준일설정 | 2021-12-14 | Korean | ||
| 8856902 | 기타경영사항(특허권취득)(자율공시)(락토바실러스 플란타럼 KBL396 균주 및 그 용도-일본) | 2021-12-10 | Korean | ||
| 8863753 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2021-11-26 | Korean | ||
| 8866745 | 증권발행결과(자율공시)(제1회차 CB) | 2021-11-19 | Korean | ||
| 8867646 | [기재정정]주요사항보고서(유상증자결정) | 2021-11-18 | Korean | ||
| 8867548 | 증권발행결과(자율공시)(제3자배정 유상증자) | 2021-11-18 | Korean | ||
| 8869648 | 분기보고서 (2021.09) | 2021-11-15 | Korean | ||
| 8883817 | 주요사항보고서(유상증자결정) | 2021-11-10 | Korean | ||
| 8883814 | 주요사항보고서(전환사채권발행결정) | 2021-11-10 | Korean | ||
| 8887778 | 기타경영사항(특허권취득)(자율공시)(클로스트리디옴 디피실레(Clostridium difficile) 성장 억제 효과를 갖는 클로스트리디움 신덴스 균주) | 2021-11-03 | Korean | ||
| 8890909 | 투자판단관련주요경영사항(마이크로바이옴 신약 후보물질 중국 등 지역(중국, 홍콩, 마카오, 대만)기술이전 계약 체결) | 2021-10-28 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
KoBioLabs, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/15084/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=15084 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=15084 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=15084 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 15084}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for KoBioLabs, Inc. (id: 15084)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.